碳酸酐酶抑制剂

碳酸酐酶抑制剂（CAIs）可抑制房水分泌而减少房水的生成，从而起到降眼压、治疗青光眼的作用。

Carbonic anhydrase inhibitors ( CAIs ) can decrease the generation of the aqueous humor by inhibiting the secretion of it , reducing the intraocular pressure for treatment of glaucoma .

用作抗青光眼药物的碳酸酐酶抑制剂

Carbonic Anhydrase Inhibitors as Antiglaucoma Drugs

目的：探讨碳酸酐酶抑制剂的局部滴眼剂Trusopt对原发性开角型青光眼的临床疗效。

To observe the clinical effect of Trusopt ( 2 % dorzolamide ) that was the first eye drops of carbonic anhydrase inhibitor ( CAI ) in glaucoma therapy .

醋甲唑胺是一种碳酸酐酶抑制剂类的抗青光眼药物，其口服制剂被广泛应用于临床。

Methazolamide ( MTZ ) is a carbonic anhydrase inhibitor widely used in oral administration in the treatment of glaucoma .

因此，不会出现全身酸中毒或其他与口服碳酸酐酶抑制剂有关的副作用。

Thus , systemic acidosis or the other side effects associated with oral carbonic anhydrase inhibitors are not expected to occur .

碳酸酐酶Ⅱ磺酰胺类抑制剂的3D-QSAR研究

3D-QSAR Study of Human Carbonic Anhydrase ⅱ Sulfonamide Inhibitors